Mumbai: Reduced hearing, dry mouth, throbbing headache and conjunctivitis are some of the newer symptoms increasingly seen in Covid-19 patients. Members of the state Covid-19 taskforce urged physicians to suspect Covid even in cases where the hallmark signs of cough, sore throat, shortness of breath are absent.
BEIJING: China on Monday reported an anthrax pneumonia patient from northern Hebei province’s Chengde city, who had contact history with cattle, sheep and products that come from these animals.
Washington: People suffering from serious long-term symptoms of coronavirus disease, also known as Long Covid, may qualify as “disablility” under federal law, US President Joe Biden has said.
Biden on Monday released guidance on federal protections and resources to those suffering from lingering Covid symptoms, such as fatigue or brain fog, which “can sometimes rise to the level of a disability”, NBC news reported.
NEW DELHI: Of India’s population above the age of six, 67.6 percent have developed antibodies against Covid-19, found the Indian Council of Medical Research’s (ICMR) fourth national serosurvey done between June 14 and July 6, the Lok Sabha was informed on Friday.
New Delhi: As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday.
According to sources, children in the above-mentioned age group have already received the first dose of the vaccine.
NEW DELHI: A total of 45,432 cases of mucormycosis have been reported by states and UTs till July 15 of which 21,085 affected people are receiving treatment and 4,252 have died, the Rajya Sabha was informed on Tuesday.
Union Health Minister Mansukh Mandaviya, speaking in Rajya Sabha on the second day of the Monsoon Session in Parliament informed that centre and states have to work as “bhagidaars” (partners) to combat the third wave of the pandemic. Added that states have been asked to submit a plan and accordingly, funds will be transferred to enable preparedness.
A sudden surge in Covid-19 cases in Russia has delayed large-scale commercial rollout of Sputnik V vaccine in India.
Europe‘s drug regulator said on Tuesday it had started a real-time review of the Covid-19 vaccine developed by French drugmaker Sanofi and Britain’s GlaxoSmithKline, the fifth shot currently under such a review.
NEW DELHI: Genome sequencing of recent samples from across the country shows that the Delta variant continues to be the dominant lineage causing new Covid-19 cases though there is strong evidence that vaccination offers a high level of protection, the Indian SARS-CoV2 Genomics Consortium (INSACOG) said.